000 | 01813 a2200565 4500 | ||
---|---|---|---|
005 | 20250514012005.0 | ||
264 | 0 | _c20020306 | |
008 | 200203s 0 0 eng d | ||
022 | _a1434-6621 | ||
024 | 7 |
_a10.1515/CCLM.2001.115 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGeisel, J | |
245 | 0 | 0 |
_aGenetic defects as important factors for moderate hyperhomocysteinemia. _h[electronic resource] |
260 |
_bClinical chemistry and laboratory medicine _cAug 2001 |
||
300 |
_a698-704 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_a5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase _xgenetics |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aCystathionine _xblood |
650 | 0 | 4 | _aDNA Mutational Analysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFerredoxin-NADP Reductase _xgenetics |
650 | 0 | 4 |
_aFolic Acid _xblood |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHomocysteine _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperhomocysteinemia _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMethylenetetrahydrofolate Reductase (NADPH2) |
650 | 0 | 4 |
_aMethylmalonic Acid _xblood |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aOxidoreductases Acting on CH-NH Group Donors _xgenetics |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 |
_aVitamin B 12 _xblood |
650 | 0 | 4 |
_aVitamin B 6 _xblood |
700 | 1 | _aZimbelmann, I | |
700 | 1 | _aSchorr, H | |
700 | 1 | _aKnapp, J P | |
700 | 1 | _aBodis, M | |
700 | 1 | _aHübner, U | |
700 | 1 | _aHerrmann, W | |
773 | 0 |
_tClinical chemistry and laboratory medicine _gvol. 39 _gno. 8 _gp. 698-704 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1515/CCLM.2001.115 _zAvailable from publisher's website |
999 |
_c11512579 _d11512579 |